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Abstract
Orthodontic tooth movement requires coordinated bone resorption and deposition in
response to mechanical stimuli. Underlying this process is a complex network of biological
signaling to activate osteoclasts and osteoblasts. The broad category of small proteins known as
cytokines include many potential mediators involved in complex interactions to initiate tooth
movement. One of the signaling factors is interleukin-1β (IL-1β), which plays a critical role in
inflammation and bone erosion via the activation of osteoclasts. IL-1β is a key cytokine
involved in osteoclast differentiation, multinucleation, and overall survival. Recently,
interleukin-17 (IL-17) has been identified as a potent inducer of inflammation that influences
bone homeostasis. IL-17 affects a broad range of cell types and enhances the production of other
pro-inflammatory cytokines, including IL-1β, IL-6 and TNF-α. To date, few studies have
examined the role of IL-17 in orthodontic tooth movement. However, studies focusing on the
role of IL-17 in bone homeostasis suggest that IL-17 may be a key mediator of bone resorption
during orthodontic tooth movement. The present study expanded upon previous research by
Faulkner (2011) which demonstrated elevated IL-6 levels in GCF within 24 hours of orthodontic
force activation. The aim of this study was to evaluate whether increased levels of bone
resorptive cytokines (IL-17 and IL-1β) can be detected in GCF from the compression
(resorptive) sites after application of orthodontic force. This study also evaluated the expression
of IL-17 and IL-1β at various time points to determine if there was a temporal relationship
between the expressions of these two cytokines. GCF samples were collected 1, 6, and 24 hours
after initial activation from mesiobuccal (MB) and distolingual (DL) sites of experimental and
control teeth from 9 patients undergoing orthodontic treatment. Control teeth were not bonded,
thus no force was applied. Patients returned in 5-7 weeks for their 1st retie activation visit. GCF
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samples were collected again at the same time intervals. GCF was sampled three times for each
site and time point and pooled for volume analysis. A Bradford assay was performed to obtain
total protein levels of each pooled sample at each time point. MILLIPLEX® MAP (multianalyte profiling) assays were used to detect IL-1β and IL-17 in the GCF samples from both the
tension and compression sites. IL-1β and IL-17 levels for both experimental and control sites
were compared with a paired t-test. Levels of IL-1β at the mesiobuccal sites peaked at 6 hours
after orthodontic force application at both the initial and retie visits. While all previous studies
reported peak expression of IL-1β at 24 hours, this present study was the only study to measure
cytokine levels at 6 hours post force activation. Levels of IL-1β peaking at 6 hours may imply
that the inflammatory response is most reactive at 6 hours post force application. Levels of IL17 peaked at the mesiobuccal site 24 hours after force application at both the initial and retie
visits. There seems to be no correlation between the temporal expression of IL-1β and IL-17. It
is possible that better detection methods or additional patients and sites may help to determine
smaller variations in IL-17 at compression and tension sites. This may also help with defining a
temporal relationship between the expressions of IL-1β and IL-17.
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Chapter 1
Introduction
The skeleton is a rigid yet dynamic organ that undergoes continuous remodeling activity
throughout life. Bone remodeling involves removal of mature or damaged bone by osteoclasts
and deposition of new bone by osteoblasts.

This turnover process is essential for the

maintenance, size, and quality of the skeleton (Hadjidakis and Androulakis, 2006). In childhood,
bone remodeling allows for the formation and growth of new bone, and for bones to grow in size
and change in shape. In adulthood, remodeling repairs damaged or fractured bone to maintain a
healthy skeleton.
In the field of orthodontics, clinicians use continuous gentle pressure from archwires to
move teeth within alveolar bone to improve dental alignment and correct malocclusions. This is
made possible by bone remodeling around the tooth. Bone remodeling in the skeleton is
controlled locally and systemically by cytokines, hormones, and other proteins.

Bone

remodeling of teeth in the oral cavity depends on a tightly regulated cascade of signals expressed
by cells within the periodontium. Alveolar bone and tissue remodeling in response to an applied
force is initiated by a complex coordination of biochemical events, thus an understanding of its
processes is of great interest to orthodontists.
During orthodontic tooth movement, the equilibrium between bone apposition and bone
resorption is disrupted. Mechanical strain from orthodontic forces causes minor reversible injury
to the alveolar bone, periodontal ligament (PDL) and surrounding periodontium. These forces
alter blood flow and change the localized electrochemical environment within the periodontal
space (d’Apuzzo et al., 2013). At the compression site, in the direction where force is applied,
constriction of the periodontal ligament microvasculature releases various chemo-attractants that
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recruit relevant inflammatory modulators to the injured site (Lindskog and Lilja 1983).
Osteoclasts, the cells responsible for bone resorption, are recruited along with other phagocytic
cells to dissolve the necrotic periodontal ligament and underlying bone and cementum.
Osteoclasts are giant multinucleated cells that are derived from hematopoietic cells from the
bone marrow (Gothlin and Gustav, 1976). The folding of their plasma membrane facing the
bone matrix is called the ruffled border, and it secretes lysosomal enzymes such as tartrate
resistant acid phosphatase and cathespin K to dissolve and resorb the underlying organic bone
matrix, mainly type 1 collagen (Blair, 1998). As a result, they form Howship‘s lacunae which
are small depressions in the bone (Gothlin and Gustav, 1976). Until osteoclasts remove the
necrotic bone, tooth movement is impeded.
Once necrotic bone is removed and the tooth is allowed to move in the direction of the
force applied, bone forming cells, osteoblasts, are recruited to the tension site and are responsible
for the production of bone matrix (King et al, 1991). Osteoblasts are found along the surface of
the bone and line the newly formed or growing layer of bone matrix.

Originating from

multipotent mesenchymal stem cells, osteoblasts produce osteoid, the non-mineralized organic
component of bone consisting primarily of collagen (Fornasier, 1977). Mineralization soon
begins after collagen deposition and slowly increases until the osteoid is fully mineralized into
mature bone (Dimitrios and Androulakis, 2006).
While there are multiple biochemical cascades that regulate bone homeostasis, one of the
most predominate pathways involve the interleukin 1 (IL-1) cytokine family as signal
transducers. One of the signaling factors is IL-1β, which induces bone erosion by activating
osteoclasts (Davidovitch et al., 1988). In addition to activating osteoclasts, IL-1β is also a key
cytokine involved in osteoclast differentiation, multinucleation, and overall survival

2

(Davidovitch et al., 1988). IL-1β has the potential to drive osteoclast differentiation via a
Receptor Activator of NF-kappaB Ligand (RANKL)/RANK-independent mechanism in microenvironmental conditions (Suda et al., 1999, Boyle et al., 2003). Although there are many
studies on IL-1β and its receptors, relatively less research has focused on its role during
orthodontic tooth movement. In addition, while IL-1β in gingival crevicular fluid (GCF) has
been measured during tooth movement at 1 hour and 24 hours after force activation (Dudic et al.,
2006), there are no studies describing the expression between 1 and 24 hours.
Interleukin17 (IL-17) is a T cell-derived cytokine that plays a role in osteoclast
development. IL-17 has been recently identified and its mechanism is not fully understood.
Research has shown that IL-17 is expressed in the early stages of immune response and acts on
osteoblasts resulting in the expression of osteoclast differentiation factor, also known as
RANKL, which induces osteoclast progenitors to differentiate into mature osteoclasts (Kotake et
al., 1999).

However, little is known about the role that IL-17 plays in orthodontic tooth

movement.
Previously, a study has been conducted to evaluate levels of IL-6 in tension vs
compression sites during orthodontic tooth movement (Faulkner et al., 2011). Cytokine levels in
GCF were examined at 0 hours, 1 hour, 6 hours and 24 hours after orthodontic force activation.
Results showed that IL-6 levels in GCF peaked at 6 hours rather than the previously accepted
peak at 24 hours. No study has been conducted to test levels of IL-1β at 6 hours after force
activation. Other studies have only evaluated its presence following 1 and 24 hours after force
application. Since IL-1β has a direct role in the chemical cascade that initiates osteoclast
production, it is of great interest to examine a more detailed timeline of IL-1β cytokine
expression.
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This present study will be the first attempt at characterizing the early expression of IL-1β
and IL-17 immediately following force activation during orthodontic tooth movement.
Comparing the levels in the compression and tension sites within 24 hours of force application
will provide data on the temporal initiation of cytokine expression as well as the timing of peak
expression during the initial stages of orthodontic tooth movement. Not only is it important to
study these cytokines as biomarkers in the biological process of tooth movement, but it is also
important to study the temporal expression of these cytokines if attempts are to be made to
maximize the rate of tooth movement, decrease overall treatment time, manage root resorption
and determine the ideal interval for retie appointments. Understanding the temporal expression
of these cytokines may also help clinicians better treat patients prone to root resorption. By
establishing a temporal relationship between orthodontic tooth movement and levels of these
cytokines, it could help clinicians establish optimal retie intervals and take advantage of these
cytokine responses to most efficiently treat their patients.

Research Questions & Hypotheses
1. Will there be increased levels of bone resorptive cytokines (IL-1β and IL-17) detected in
GCF from the compression (resorptive) sites after application of orthodontic force?
H0: Increased levels of bone resorptive cytokines will be not be detected in GCF from the
compression sites after application of orthodontic force.
HA: Increased levels of bone resorptive cytokines will be detected in GCF from the
compression sites after application of orthodontic force.
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2. Will the largest increase (peak) in the level of bone resorptive cytokines (IL-1β and IL17) be detected within 24 hours (1 or 6 hr time points) after orthodontic force
application?
H0: The largest increase in the level of bone resorptive cytokines will be detected at 24
hours or more after orthodontic force application.
HA: The largest increase in the level of bone resorptive cytokines will be detected within
24 hours after orthodontic force application.
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Chapter II
Literature Review

Orthodontic tooth movement occurs when a force is placed on a tooth causing
compressive force against the PDL and bone. As a response to this constant mechanical force,
the PDL and bone remodel, which allows the tooth to move. Bone resorbs in the direction of
force applied and bone deposits on the side from where the tooth has been displaced. This
combination of movement allows teeth to change position within alveolar bone.

Thus, in

orthodontic tooth movement, there are two distinct opposite sides that are referred to as the
tension site, where displacement of tooth causes a force to the PDL causing bone formation, and
a compression site, where compressive forces are generated by the root moving against bone
causing the bone to resorb (Sandstedt, 1904).
Phases of tooth Movement
In essence, tooth movement can be divided into three stages. Burstone (1962) outlined
tooth movement in 3 phases: an initial phase, a lag phase, and a post lag phase.
In the initial phase, there is immediate tooth movement almost immediately after force
application. This is due to relatively unhindered movement within the PDL space. After the
initial phase, there is a lag period with little to no displacement of the tooth. This lag phase is
associated with hyalinization in compressed regions of the PDL (Dalstra et al., 2006).
Hyalinization is the sterile necrosis of tissues that occurs in local pressure zones. Although
orthodontists try to use gentle light forces, hyalinization is almost unavoidable. The alveolar
bone surface is rough and jagged, thus even light forces may produce high enough stress to cause
hyalinization (Dalstra et al., 2006). These hyalinized areas cannot generate and signal progenitor
cells to differentiate into osteoclasts. Osteoclasts are needed from undamaged adjacent marrow
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cells to remove the necrotic tissue: This is referred to as undermining resorption (von Bohl and
Kuijpers-Jagtman, 2008). No tooth movement occurs until all necrotic hyalinized tissues have
been removed. After this lag phase comes the post lag phase where the rate of movement is
suddenly increased and tapers to become a steady gradual movement (Burstone, 1962).
An additional study completed by Pilon et al. (1996) further defined phases of tooth
movement. They categorized tooth movement into four phases with distinct time points. In the
study, phase 1 lasted 3 - 4 days or less for 75% of the cases. The first phase accounts for the
initial tooth movement within the PDL socket. The second phase, also known as the arrest
phase, is associated with little to no tooth movement due to hyalinization of the PDL. Phase two
usually lasts 4-20 days after force activation. Phase 3 is characterized by an accelerated rate of
tooth movement, suggesting that remodeling in this stage is at its peak capacity. Phase 4 is
characterized by a linear rate of tooth movement. In Phase 4, the tension side shows osteoblastic
proliferation and activity. Pericytes, which are fibroblast like cells that line the PDL capillaries,
recruit osteoblast progenitor cells to start producing new bone matrix. Tooth movement during
phases 3 and 4 are continuous and not interrupted.
Theories of Orthodontic Tooth Movement
Historically, there have been many theories describing the mechanisms of orthodontic
tooth movement. The following reviews the most widely accepted theories.
Pressure Tension Theory
The pressure and tension theory is a culmination of research published by Sandstedt
(1904), Oppenheim (1911), and Schwartz (1932). It states that when a force is placed on a tooth,
the tooth reacts and moves within the periodontal space due to cellular changes produced by
chemical messengers in the periodontium. It then generates a “pressure side” and a “tension
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side”. Force on the pressure side causes alteration in blow flow associated with compression
within the PDL and causes cell death (Schwartz, 1932). Vasodilation leads to the formation and
release of chemical messengers which activates specific cells for orthodontic tooth movement.
When the PDL is mechanically stimulated osteoclasts appear within 48 hours. The first-wave
arrives from a local cell population within the PDL. The second wave is brought from distant
areas via chemical signaling. Osteoclasts proceed to remove the dead bone cells which lead to
tooth movement. On the tension side, the PDL fiber bundles are stretched to stimulate blood
flow and promote osteoblastic activity and osteoid deposition. This heightened osteoblastic
activity results in fiber production and deposition of newly formed bone.
Bone Bending Theory
Farrar (1888) theorized that alveolar bone bending leads to orthodontic tooth movement.
Further research from Baumrind (1969) confirmed his hypothesis. Baumrind stated that the PDL
is a continuous hydrostatic system that diffuses forces evenly so there is no distinct pressure or
tension side. His hypothesis, called the bone bending theory, states that orthodontic forces are
transmitted to all tissues near its application and bends the bone, tooth and surrounding
periodontium. Bone is elastic in nature and bends readily in response to force. When bone is
bent and held in the new deformed position, active biologic processes begin the bone turnover
process. These biologic signals originate from agitated cells lying perpendicular to stress lines
created by the bone bends. As bone modifies and restructures to accommodate forces acting on
it, the tooth moves and forces dissipate. The bone bending cycle starts all over when new force
is applied, such as during the patient’s retie appointments where stiffer and larger wires are
placed.

Grimm (1970) discovered that alveolar bone bending accounts for 0.6-25% of total
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tooth movement. This proved that mechanical strain in bone is one of the mediating factors
which convert an extrinsic force to cellular bone response.
Bioelectric Signals
The bioelectric signals theory proposes that exogenous forces create electric potentials in
stressed tissue. These electric potential charges cause macromolecules to bind to or move across
cell membranes to induce bone turnover (Bassett and Becker, 1962). Previous studies on the
skeleton showed that osteogenesis can be triggered by placing appropriate currents on long bones
(Friedenberg et al., 1970). To apply this theory to orthodontic tooth movement, Zengo et al.
(1974) measured stressed induced electric potentials from the dentoalveolar complex during
application of orthodontic force in beagles. The study resulted in the discovery that the concave
surfaces of stressed bone is charged with electronegative potentials which showed elevated
osteoblastic activity and the electropositive signals from convex surfaces showed greater
osteoclastic activity.

The study linked bioelectric responses from bone bending, both

piezoelectric and streaming potentials, to orthodontic tooth movement.
From each theory’s initial proposal to now, ongoing studies have not proved nor
disproved one hypothesis to be the evident truth. However, the pressure and tension theory is
most widely accepted. Recent studies have suggested that both physical and biologic processes
are needed for tooth movement, with force application, tissue cells, alveolar bone, and PDL
responding cohesively to initiate bone remodeling.
Cytokines
Cytokines are soluble secreted proteins released by cells and are primarily involved in
cellular interaction and communication (Zhang and An, 2009). Cytokines have the ability to act
on cells that secrete them, on a cell close by or far away, and some are pro-inflammatory while
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others are anti-inflammatory. These proteins function as intercellular messengers and regulate
cellular activity throughout the body. Cytokines are pleiotropic, meaning a single cytokine can
cause different effects depending on the cell types they bind to or interact with. One cytokine
can stimulate varying effects on target cells depending on the microenvironment (Simpson et al.,
1997). Certain cytokines can also influence similar biological pathways and may even have
common receptors (Simpson et al., 1997).
Cytokines are needed to initiate bone turnover during orthodontic tooth movement. The
transduction of forces on PDL and bone triggers a cellular biological response mediated by
inflammatory cytokines that are responsible for tissue and bone remodeling. Orthodontic forces
result in an increase of PDL neurotransmitters such as substance P, which causes vasodilation
and production of inflammatory cells and cytokines (Norvall et al., 1998). Once they arrive to
the local injury site, cytokines and inflammatory mediators act as signaling proteins to directly
influence bone remodeling (Davidovitch et al., 1988). Some important cytokines that are
involved in bone metabolism include RANK, RANKL, OPG, bone morphogenetic proteins
(BMPs), interleukin 1 family, interleukin 6, interleukin 17, and TNF-α in addition to many others
(Krishnan & Davidovitch, 2009).
RANK/RANKL/OPG
Understanding the relationship between RANK, its ligand (RANKL), and osteoprotegerin
(OPG) was a pivotal discovery that clarified the roles of osteoblasts and stromal cells in bone
homeostasis. This pathway has been crucial in understanding osteoclast formation and activation.
RANK is a type I homotrimeric transmembrane protein and is expressed in a variety of cells
(Boyce and Xing, 2007). RANKL is a type II homotrimeric transmembrane protein (Ikeda et.al,
2001) that is derived from the TNF family and is essential for bone metabolism.
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RANKL

regulates the development, maintenance and activation of osteoclasts. It is expressed by
osteoblasts and stimulates local osteoclasts to resorb bone which in turn stimulates local
osteoblasts to synthesize bone.

This feedback process called “coupling”, helps maintain

harmony and balance (Udagawa et al., 2000). Most factors that stimulate osteoclast formation
also stimulate RANKL expression in osteoblasts. RANKL is also highly expressed in immune
regulating tissues such as lymph nodes and thymus. OPG is a homodimer protein that serves to
protect against bone loss and is expressed in osteoblasts, bone marrow, spleen and heart tissues
(Wada et al., 2006). It is secreted by osteoblasts and osteogenic stem cells to upregulate bone
density (Simonet et al., 1997).
Osteoblasts produce both RANKL, which initiates bone resorption, and OPG, which
inhibits bone resorption. (Kearns et al., 2008; Khosla, 2001). When RANK binds to RANKL
osteoclastogenesis is initiated and osteoclasts are activated. However OPG serves as a soluble
decoy receptor to RANKL (Simonet et al, 1997). Both OPG and RANK show affinity to the
RANKL, thus OPG competes with RANK to bind to RANKL. When OPG binds to RANKL, it
prevents the cell to cell signaling of RANKL on osteoclast precursors resulting in inhibition of
osteoclastogenesis (Yasuda et al, 1998).

The OPG–RANKL complex counterpoises the effect

of the RANK–RANKL complex, thus playing an important role in bone homeostasis and
metabolism. If OPG is not produced, RANKL exclusively and freely binds to RANK and begins
the osteoclastogenesis pathway. This is further proven in knock-out studies of OPG in mice
which lead to severe osteoporosis with spontaneous fractures (Yasuda et al., 1998).

RANKL

has a different effect on osteoclastogenesis depending whether it binds to RANK or OPG. This
signaling pathway is essential for bone homeostasis and a disruption of either cell can lead to
metabolic bone diseases (Kohli, Kohli 2011).
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Biomarkers
A biomarker is substance that is measured and used as an indicator of biologic processes
and pathological processes (Strimbu and Tavel, 2010). The United Nations and International
Labor Organization defined a biomarker as “any substance, structure or process that can be
measured in the body or its products and influence or predict the incidence or outcome of
disease” (WHO). A biomarker should be specific and sensitive so it can provide information
about the changing biological conditions. IL-1β is a proven biomarker for cellular changes
during orthodontic tooth movement (Kumar et al., 2015). Many studies have found elevated
levels of IL-1β in GCF from experimental teeth after force is applied (Grieve et al, 1994,
Uematsu et al, 1996, Salla et al, 2012). In summation, their studies concluded that the increase
of IL-1β is associated with bone remodeling during orthodontic tooth movement. IL-17 has been
studied less extensively. Although there are studies quantifying levels of IL-17 in patients with
root resorption associated with orthodontic treatment, and in patients with periodontitis, no study
has evaluated if IL-17 is associated with normal orthodontic tooth movement and bone
remodeling. Further knowledge of these biomarkers gained from this present study may be used
to identify changes in the periodontal microenvironment and may be clinically useful to help
improve and shorten orthodontic treatment.
IL-Iβ
There are 11 members of the Interleukin 1 (IL-1) family of ligands. IL-1β is part of the
IL-1 cytokine family and is critical to immune response and function. IL-1β in particular has
been extensively studied due to its control over inflammation at the receptor and nuclear levels.
(Weber et al., 2010).
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IL-1β is released from a wide variety of cells including keratinocytes, fibroblasts,
synoviocytes, endothelial, neuronal and immune macrophage and mast cells (Ren and Torres,
2009). IL-1β can induce gene expression and synthesis of many proteins that cause fever,
lowered pain threshold, vasodilatation, and hypotension including cyclooxygenase type 2 (COX2), type 2 phospholipase A, and prostaglandin-E2 (PGE2). This also affects immune responses
as PGE2 is a common mechanism for nonspecific suppression of T cell responses (Ren and
Torres, 2009).

In addition to inducing the production of certain chemokines, IL-1β also

increases the expression of adhesion molecules and promotes the infiltration of inflammatory and
immunocompetent cells from circulation into extravascular spaces to increase inflammation in
tissues (Dinarello, 2009).
In the periodontium, IL-1β is released from fibroblasts, macrophages, cementoblasts,
osteoblasts and osteoclasts (Alhashimi et al., 2001) in response to mechanical stress. At the
biochemical level, orthodontic forces stimulate the release of prostaglandins, growth factors and
cytokines, including IL-1β. Studies have shown that an increase in IL-1β correlates with the
increase in osteoclast numbers (Alhashimi et al., 2001), suggesting that this cytokine is an
important initiator of osteoclastogenesis. During the initial stages of tooth movement, IL-1β is
secreted by osteoclasts as a response to mechanical force. In the later stages, IL-1β is secreted
by macrophages that have accumulated at compressed areas (Davidovitch et al., 1988). IL-1β
recruits other inflammatory cells to the damaged tissue site and binds to its receptor on the
surface of pro-osteoblastic cells and can activate both RANKL and OPG genes. The ubiquitous
nature of IL-1β combined with the increased expression in both RANK and RANKL are needed
to remodel the periodontium and resolve tissue stress from orthodontic forces.
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To further demonstrate IL-1β’s role in orthodontic tooth movement, studies using
exogenous injections of interleukin-1 receptor antagonist (IL-1Ra) of IL-1β have been
conducted. Salla et al. (2012) injected IL-1Ra, a naturally occurring IL-1β antagonist, in mice to
determine its effects on tooth movement. They discovered that mice treated with IL-1Ra showed
diminished orthodontic tooth movement and a decreased number of TRAP positive osteoclasts
compared to the untreated group. In the treated groups, ELISA analysis revealed lower levels of
IL-1β and TNF-α. Iwasaki et al. (2006) also examined the relationship between levels of IL-1β
and velocity of tooth movement. It was concluded that elevated levels of IL-1β are associated
with faster tooth movement. Iwasaki et al. conducted an additional study in 2009 to further
investigate the biologic factors that affected tooth movement, particularly IL-1β and IL-1Ra.
They analyzed GCF samples on canines that were distally translated under varying force levels.
Their conclusion supports other studies fortifying the idea that increased levels of IL-1β and
decreased levels of IL-1Ra are associated with accelerated tooth movement.
With applied mechanical forces, fibroblasts, macrophages and cementoblasts produce IL1β which diffuses into the gingival crevicular fluid. Studies have been conducted to evaluate the
concentrations of IL-1β during orthodontic tooth movements at 0, 1, 24, and 48 hours after force
application (Grieve et al, 1994). Concentrations of IL-1β peaked at 1 and 24 hours with 24 hours
being the highest (Grieve et al, 1994). However, the peak elevation or significant changes within
24 hours is unknown. Our study aims to verify these established conclusions and also add to the
timeline of IL-1β expression by evaluating levels at 0, 1, 6 and 24 hours after force activation.
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IL-17
IL-17 is an inflammatory cytokine that is produced by activated T-helper 17 cells (Th17)
from T-helper 1 precursors (Yao et al., 1995). Studies have shown that IL-17 acts as a crucial
mediator of many autoimmune diseases such as multiple sclerosis, asthma and rheumatoid
arthritis (Agache et al., 2010, Al-Saadany et al., 2016). IL-17 has been shown to stimulate the
expression of RANKL in synovial cells in rheumatoid arthritis. Functionally, IL-17 mediates
pro-inflammatory responses in host defense and inflammatory diseases.

IL-17 promotes the

production of cytokines and chemokines to attract neutrophils and macrophages to inflammation
sites. IL-17 receptors are commonly expressed on fibroblasts and epithelial cells, and among
innate immune cells, such as macrophages and neutrophils (Jin and Dong 2013).
Due to its extensive involvement in the inflammatory pathway especially with
rheumatoid arthritis, most studies have examined the role of IL-17 in pathologic skeletal
remodeling.

Until recently, IL-17’s role in bone remodeling was not clear.

But recent

discoveries have identified that IL-17 stimulates the production of MCSF and RANKL in
osteoblast and mesenchymal stem cells (Lee, 2013). This action leads to a greater production of
osteoclasts to shift the balance of bone homeostasis to bone resorption. When IL-17 is in the
presence of inflammatory cytokines, the combination induces the differentiation and activation
of osteoclasts (Sato et al., 2006). In addition, specifically in the presence of TNF-α, IL-17
induces bone resorption in long bones in mice (Van bezooijen et al., 1999).
IL-17 has also been associated with the pathogenesis of periodontitis via induction of
RANKL production by osteoclasts.

Th17 cells and IL-17 have been detected in patients with

chronic periodontitis and IL-17 levels were significantly higher in severe periodontal lesions
compared with other T-helper secreted cytokines (Cardosa et al., 2008). Takahashi et al. (2005)
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reviewed its role in the immunopathology of periodontal disease and concluded that IL-17 is
produced locally in periodontal lesion sites from activated gingival T cells. In the periodontal
lesions, IL-17 induces the production of IL-6, RANK and RANKL, all of which are cytokines
that increase bone resorption (Yamaguchi et al., 2012). Beklen et al. (2007) reviewed IL-17’s
role in bone destruction in periodontitis via a different cellular pathway – the upregulation of
tissue-destruction matrix metalloproteinases (MMP). The authors concluded that IL-17 increases
the presence of MMP indirectly by inducing IL-1β and TNF-α production in macrophages and
IL-6 from gingival fibroblasts. Together, these cytokines regulate MMP which leads to the
degradation of interstitial and membrane collagens.
In addition to bone resorption, IL-17 also pays a role in bone formation. Huang et al.
(2006) stated that IL-17 is a growth factor for mesenchymal stem cells by stimulating the
formation of colony forming unit-fibroblasts in marrow stromal cells. In another study by Kocic
et al. (2012), IL-17 was shown to divert the differentiation of the myoblastic cell line C2C12 into
an osteoblastic pathway.

Both studies concluded that IL-17 is capable of steering the

differentiation of mesenchymal stem cells into an osteogenic lineage.
Currently, IL-17’s relationship with orthodontic tooth movement is not entirely clear but
its role in rheumatoid arthritis and periodontitis as well as normal bone remodeling solidified its
importance in bone metabolism. Studies have shown that excessive compressive forces during
orthodontic tooth movement stimulate the expression of IL-17 which contributes to the
osteoclastogenesis cascade (Nakano et al., 2015). Studies have also identified IL-17 as a proinflammatory cytokine for osteoclastic bone resorption during orthodontic tooth movement. IL17 leads to the production of IL-1β, IL-6, and IL-8 which are all biomarkers for bone resorption
(Gu et al., 2008). More recently, studies have linked IL-17 expression during orthodontic tooth
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movement with a higher rate of root resorption via cytokine production of IL-6 to stimulate
osteoclastogenesis and odontoclastogenesis. Higher levels of Th17 cells and IL-17 have been
detected in bone slices exposed to higher orthodontic forces compared to lower orthodontic
forces. (Hayashi et al., 2011). Evidence suggests that IL-17 may be very important in tooth
movement, but we do not fully understand its exact role. By evaluating levels of 1L -17 at
various hours after force activation, we aim to learn more about its involvement and expression
patterns during orthodontic tooth movement.
In this present study, the aim is to evaluate IL-17’s presence in tension vs compression
sites during orthodontic tooth movement. Since IL-17 plays a role in both osteoblast and
osteoclast formation, it is hypothesized that its presence will be detected at both sites.
Gingival Crevicular Fluid
The gingival sulcus is a shallow crevice that is bound by tooth surface on one side and
epithelial lining of the free gingival margin on the other. The fluid in the structure, called
gingival crevicular fluid, (GCF) is an osmotically mediated inflammatory exudate that tends to
increase in volume during tissue damage and inflammation from increased capillary permeability
(Yamaguchi, 2009). Pashley (1975) concluded that increased GCF production is attributed to the
increased rate of capillary transduction.
Waerhuag (1950) first studied the transforming anatomy of the sulcus during the course
of periodontal disease. Since then, numerous studies have proven that GCF is a reliable medium
to measure a multitude of biological markers and bacteria present in the oral cavity and PDL
space (Griffiths et al, 1992). While GCF is primarily composed of serum with enzymatic and
non-enzymatic components, the composition can be influenced by the surrounding gingival
tissue and bacteria (Cimasoni, 1983). Inflammatory mediators increase capillary pressure to
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increase leakage of proteins into the interstitial fluid (Pashley, 1975). As such, GCF can be
found to contain a variety of substances including immunoglobulins, microorganisms, toxins,
cells, electrolytes and lysosomal enzymes (Yamaguchi, 2009). Since tissue remodeling in
orthodontic tooth movement is initiated by the inflammation process, it has been observed that
biomarkers of bone remodeling can be found within GCF as well (Lamster and Novak, 1992).
Studies have shown that quantification and identification of cells and proteins in GCF can
accurately reflect the immune and inflammatory pathways in patients with periodontitis and in
patients undergoing orthodontic treatment (Lamster, 1992; McCulloch, 1994; Ren et al., 2002;
Ren et al., 2007). During orthodontic tooth movement, increased levels of prostaglandin E, IL1β, IL-6, tumor necrosis factor were reported in GCF (Grieve et al., 1994). GCF collection is a
reliable non-invasive simple method to study a variety of biological markers without disturbing
the integrity of marginal tissues.
GCF Levels of IL-1β and IL-17
While many studies have used GCF levels to study the inflammatory presence during
active periodontal disease, fewer studies have examined similar markers during orthodontic tooth
movement. Studies examining the levels of IL-1β in GCF during tension vs compression sites
during orthodontic force application have limited time points at 1 and 24 hours after force
activation.

Grieve et al. (1994) found a peak increase in IL-1β after 24 hours of force

application.

Uematsu et al. (1996) has also found that GCF levels of IL-6, TNF-α, and

epidermal growth factor were all significantly higher at 24 hours after force application during
orthodontic tooth movement. However, these studies did not evaluate any time points between 1
and 24 hours post-orthodontic force activation. Presently, there are no studies characterizing the
levels of IL-17 during orthodontic tooth movement comparing compression vs tension sites at
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any time point. This present study aims to examine levels of IL-1β and IL-17 in GCF at 0, 1, 6
and 24 hours after orthodontic force application.
Summary
Orthodontic tooth movement is a complex biological phenomenon that involves a
coordinated symphony of molecular signaling and interactions. This process has been
documented by the four stages of tooth movement. Studies have shown that during the initial
stages of bone remodeling, IL-1β is critical in initiating bone resorption via the activation of
osteoclasts.

This current study examines the presence of IL-1β and IL-17 in GCF during

orthodontic tooth movement to determine if there is a correlation between peak levels of IL-1β
and IL-17 and if they exhibit the same temporal expression pattern. The hypothesis is that the
highest level of IL-1β detected in GCF occurs earlier than 24 hours after orthodontic force
application. In addition, levels of IL-I7 in GCF will also peak prior to 24 hours and will follow a
similar expression pattern as IL-1β.

This knowledge may help orthodontists with establishing

activation intervals and may support the need for future studies to examine the mechanisms of
accelerated orthodontic tooth movement. This knowledge will also help scientists understand
more about the temporal behavior, possible similarities, and potential relationships of IL-1β and
IL-17 in initiating orthodontic tooth movement, and examine if their expression and recruitment
behavior is in concert or related.
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Chapter III
Materials and Methods

Study Population
Gingival crevicular fluid samples were collected by Mathue Faulkner, DDS, MS from
nine orthodontic patients [5 males, 4 females, age range from 11 to 31 years (mean 17.445
years)], treated at the University of Nevada, Las Vegas School of Dental Medicine Orthodontic
Clinic. All patients were asked to participate in the study during their initial screening
appointment and consent was obtained prior to sampling and beginning orthodontic treatment.
Research protocol and consent forms were approved by the Office of Research Integrity –
Human Subjects (02/22/11 by Faulkner). All patients participating in this study consented that
their GCF samples could be used in future studies as well. IRB approval was obtained for this
additional study using these previously collected samples (IRB exempt approval 11/8/2017 by
Wen).
All patients were determined to be appropriate candidates to receive orthodontic
treatment with fixed appliances. The inclusion criteria for this study consisted of: no selfreported use of anti-inflammatory medications, good periodontal health (generalized probing
depths ≤ 3mm and no radiographic evidence of periodontal bone loss), and the presence of one
or more teeth that did not require immediate orthodontic movement to serve as control teeth.
Patient exclusion from this study included: presence of periodontal disease and/or moderate to
severe gingivitis, only minimal required tooth movement, diabetes, self-reported use of antiinflammatory medication within the last 30 days, history of bleeding problems, use of tobacco,
and/or poor oral hygiene.
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Data Collection
Pre-treatment records of intraoral and extra-oral photographs, panoramic and
cephalometric radiographs, and study models were obtained for each patient. Before bonding,
patient’s oral and periodontal health was assessed. Probing depths, bleeding on probing (BOP),
and a plaque index (PI) were performed and recorded at both initial and retie visits. The
experimental tooth was chosen by evaluating the amount of predicted movement from initial
models and ease sample collection. The experimental teeth consisted of five maxillary lateral
incisors, three mandibular lateral incisors, and one maxillary central incisor (Table 1). Tension
and compression sites were predicted from evaluating preliminary study models and calculating
the direction of movement the tooth would undergo. The selected control tooth per patient was
teeth that did not require great movement or immediate orthodontic bonding. Of the nine selected
control teeth, one was a maxillary lateral incisor, one was a maxillary canine, one was a
mandibular canine, two were mandibular incisors, two were mandibular premolars, and two were
maxillary premolars (Table 1). The control teeth were not bonded, thus no force was applied
until the completion of this study.
Table 1. List of Control and Experimental Teeth
Experimental Teeth
Maxillary Lateral Incisor
Mandibular Lateral Incisor
Maxillary Central Incisor

Count
5
3
1

Control Teeth
Maxillary Lateral Incisor
Maxillary Canine
Mandibular Canine
Mandibular Central Incisor
Mandibular Premolar
Maxillary Premolar

Count
1
1
1
2
2
2
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GCF samples were collected before bracket placement at three separate sites for each
patient.

These sample sites were the mesiobuccal (MB) and distolingual (DL) of the

experimental teeth as well as the mesiobuccal of the control teeth. Isolation was achieved with
cotton rolls and teeth were carefully dried with air. Periopaper (Oraflow, Smithtown, New York)
was gently inserted into the sulci to collect the GCF from each site for approximately 90
seconds. Samples were collected three individual times per site. The Periopaper was then
placed in a Periotron 6000 (Oraflow, Smithtown, New York) to quantify total GCF volume
collected from each site. The three Periopapers from the same site per patient were placed in a
single vial diluted with 200 μL of 1X phosphate buffered saline (PBS). The vials were stored in
a standard freezer until all samples were collected and processed. All vials were moved to a
-20°C freezer on the same day and kept frozen until assay.
Following the initial sample collection (0 hrs), patients had brackets placed except for the
control teeth. A 0.012 or 0.014 Nickel Titanium arch wire was used to align teeth and apply
gentle orthodontic force.

One hour after the wire was placed, GCF samples were collected in

the same manner as the initial samples. At the 6 and 24 hours time point, GCF samples were also
collected with the same protocol as the initial samples.
After 5-7 weeks from initial bonding, patients returned for their first retie appointment to
re-activate orthodontic forces. Patients’ periodontal health was assessed again by measuring
probing depths, BOP, and PI. Exclusion criteria were reevaluated for each patient and no patients
were eliminated from the study based on presence of periodontal disease and/or moderate to
severe gingivitis and/or poor oral hygiene. GCF was collected after the periodontal exam prior to
untying the wire or applying new orthodontic force. This represented the 0 hr time point at the
retie appointment. Seven of the nine patients could progress to a thicker wire and had a 0.016 or
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0.018 Nickel Titanium arch wire placed. The initial arch wire was removed and retied for the
remaining two patients since a larger wire could not be effectively engaged in the mal-aligned
experimental teeth. Samples were again collected 1, 6, and 24 hours after orthodontic forces
application using the same data collection protocol. All patient samples from the initial and retie
visits were collected and processed by Mathue Faulkner (2011).
GCF Volume Measurement
To calibrate the Periotron 6000, 14 sequentially increasing known fluid volumes (0.1-1.4
μL) of fetal bovine serum (FBS) was added to Periopaper strips and placed in the Periotron for
analysis. Each volume was tested and recorded three times to minimize error. The mean value
per volume was calculated and a calibration curve was plotted using MasterPlex 2010 (Hitachi
Solutions) analysis software to generate a conversion coefficient. A standard calibration curve
using a fourth polynomial regression equation was formulated from the mean values, and was
used to convert the samples from the Periopapers into volumes. The three volumes obtained per
sample site were added together to calculate total GCF volume per sample.
GCF Protein Concentration
The protein concentrations in collected GCF samples were determined by a commercially
available protein assay reagent based upon the Bradford method of protein concentration
determination (Bradford, 1976). Each sample (20 μl) was combined with 275 μl of Protein Dye
Reagent (Bio-Rad, Hercules, CA) after the microtiter plate assay as directed by the manufacturer.
After a 10 minute room temperature incubation with shaking, the absorbance at 595 nm was
determined using a SpectaMax Plus (Molecular Devices, Sunnyvale, CA) microplate
spectrophotometer. Bovine serum albumin was used as the protein standards for generation of
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the standard curve and unknown concentrations were calculated. All standards and samples were
assayed in duplicate.
IL-1β and IL-17 Levels in GCF
IL-1β and IL-17 levels in GCF were analyzed with a MILLIPLEX MAP assays kit
(Millipore, Billercia, MA) according to manufacturer’s instructions. To prepare the samples for
the multiplex assay, patient samples were thawed on ice and vortexed for 30 seconds, and
sonicated for 30 seconds. Wash buffer (200 μL) was added to the 96-well plate and placed on
plate shaker to be agitated for 10 minutes. Wash buffer was decanted and 25 μL of provided
standard or control samples were added into appropriate wells. Assay buffer (25 μL) was added
to background and sample wells. Millipore matrix solution (25 μL) was added to background,
standards and control wells. Patient samples (25 μL) were added to corresponding sample wells.
Beads (25 μL) were added into each well. The plates were then incubated overnight at 4 ºC on a
plate shaker at 500rpm.
Table 2. Components Added to Each Assay Well
Millipore
Background
Millipore
Standards
(IL-1β and IL-17)
Millipore
Quality Control
Samples
Assay Buffer
GCF Samples
(experimental and
control sites)
Matrix Solution
Beads
Total μL in wells

Millipore
Standards

Millipore
Quality
Controls

Samples
(Experimental and
Control Sites)

25 μL
25 μL
25 μL

25 μL
25 μL
75 μL

25 μL
25 μL
25 μL
25 μL
75 μL
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25 μL
25 μL
75 μL

25 μL
75 μL

After overnight incubation and agitation, well contents were removed by washing the
plate 2 times with gentle vacuuming (BioTek, Winnoski, VT). Detection Antibodies (25 μL)
were added per well and incubated for 1 hour on a plate shaker at room temperature.
Strepavidin-Phycoerythrin (25 μL) was then added per well and incubated for 30 minutes on a
plate shaker at room temperature. After 30 minutes of agitation, well contents were gently
removed with a Bio-Tek ELx405 plate washer (BioTek, Winnoski, VT) twice. Sheath Fluid
(150 μL) was added to all wells and the 96 well plate was placed on plate shaker to resuspend
beads for 5 minutes.
The sample plates were analyzed on a Luminex 200 (Luminex Corp., Austin, TX). Raw
data was exported from the Luminex 200 and standard curves and unknowns were analyzed
using xPONENT software (Luminex Corp., Austin, TX, Version 3.1) with results expressed as
fg/𝜇g of total protein in GCF.
Statistical Analysis
The mean values for GCF volume, total protein, IL-1β and IL-17 for both experimental
sites and the control site were compared using Student’s t test using Microsoft Excel (2010).
Significance was set at p < 0.1. Student’s t-tests were performed comparing data within each
time point, and across all time points.
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Chapter IV
Results
Patient and Sample Characteristics
Five male and four female UNLV orthodontic patients, ages 11 to 31, were recruited to
participate in this study (Table 3).

At each time point, samples were collected from the

mesiobuccal and distolingual of the experimental teeth and the mesiobuccal site of the control
teeth during the initial and retie appointments. Periopaper (Oraflow, Smithtown, New York) was
used to collect GCF samples and were then placed in a Periotron 6000 (Oraflow, Smithtown,
New York) to convert fluids into volume measurements. This procedure was repeated three times
per sampling site, and the three Periopaper samples for each site were placed in a single vial
diluted with phosphate buffered saline (PBS).

At the recall appointment, two sets of samples

were not collected due to conflict with patients’ schedules (Table 4).

Table 3. Patient Characteristics
Sex
Male
Female

n
5
4

Age
Mean
Max
Min

n
17.4
31.3
11.2
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Table 4. Summary of GCF Samples Collected

Initial

Recall (5-7 weeks)

Post Activation
(Hours)
0
1
6
24
0
1
6
24

Total

Test Site
MB (n)
9
9
9
9
9
8
9
8
70

Test Site
DL (n)
9
9
9
9
9
8
9
8
70

Control Site
MB (n)
9
9
9
9
9
8
9
8
70
=210

Gingival Crevicular Fluid Volume
A standard curve was generated to convert Periotron readings for each Periopaper into
GCF volume (μL). The standard curve was generated by analyzing readings from Periopaper
absorbed with sequentially known volumes of fetal bovine serum (Figure 1). Recorded Periotron
readings for each Periopaper were then converted into GCF volume for analysis and total GCF
for each sample was calculated by adding together the individual readings for each of the 3
Periopapers that constitute a single sample.
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Figure 1. Conversion of Periotron Reading to GCF Volume (μL)
Figure from Faulkner, 2011

The GCF volumes were measured to determine if there were differences in volumes from
each time point during orthodontic tooth movement. The measurements of GCF volumes for
control and experimental sites (MB and DL) at each time point including both the initial (first)
and recall (second) appointments are described in Figure 2. The GCF volume for control teeth
ranged from 0.1 μL to 1.9 μL. The GCF volumes for experimental teeth had a greater range of
0.1 μL to 4.3 μL. Mean GCF volumes were calculated for each time point. The difference in
amount collected between the mean GCF volumes of the experimental samples from the initial
visit (1.13 ± 0.50 μL) and the mean GCF volumes of the experimental samples from the recall
visit (1.05 ± 0.50 μL) was not statistically significant (p=0.25). Both the control sample mean
GCF volumes measured from the initial appointment (0.80 ± 0.22 μL) and recall appointment
(0.85 ± 0.32 μL) were not statistically significant (p=0.26). However, when comparing the mean
GCF volumes of the experimental samples to the mean GCF volumes of the control samples,
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there was a statistically significant difference in volume size for both the initial appointment (p=
0.009) and the recall appointment (p= 0.05) (Figure 2).

Figure 2. Total GCF Volume Collected During First and Second Visit
The difference in GCF volumes between the first and second visit for both control and
experimental samples were not statistically significant. There is a significant increase in the
amount of GCF collected from experimental teeth versus control teeth at both the initial and
recall visits (p< 0.1). Figure from Faulkner, 2011.

During initial and recall appointments, there is a statistically significant increase in GCF
volume at 6 hours compared to all time points from the experimental samples collected (p<0.1).
The difference in experimental and control mean GCF volumes were statistically significant at
the 1 hour (p=0.08), 6 hour (p=0.02) and 24 hour (p=0.03) time points. Experimental mean GCF
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volumes were all higher than control mean GCF volumes at all time points after orthodontic
force was applied. When evaluating the control mean GCF volumes across all time points, the
differences were not statistically significant (Figure 3).

Figure 3. GCF Volumes Reported in Hours since Activation
The experimental mean GCF volumes had a statistically significant increase at the 6-hour time
point compared to all other experimental time points (p< 0.1). There was a statistical significant
difference in mean GCF volumes between experimental and control samples at 1 hour (*p=0.08),
6 hours (* p=0.02) and 24 hours (* p=0.03). Figure from Faulkner, 2011.

Gingival Crevicular Fluid Protein Levels
A Bradford assay (1976) was used to determine the protein concentration in each sample
of GCF. Known quantities of bovine serum albumin were used as protein standards and the
protein concentrations were plotted against the observed absorbance at 595 nm (Figure 4).
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Figure 4: Standard Curve for Bradford Assay
Known quantities of BSA were measured at absorbance of 595 nm on a spectrophotometer
(Molecular Devises SpectraMax) to create the standard curve. Bradford analysis was completed
in duplicate with 20 μL of sample to determine the protein concentration (μg/mL) in eluted
samples. Figure from Faulkner, 2011.
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IL-1β Levels
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Figure 5: Levels of IL-1β at MB sites during Initial Visit Time Points
There was a statistically significant increase in IL-1β levels at 6 hours (p=0.01) and 24 hours (p=
0.07) on the MB of the experimental teeth relative to the 1 hour time point. Values are shown as
fg of IL-1β per μg of total protein.
Elevated levels of IL-1β at the MB site were detected at 6 and 24 hours during the initial
visit time points. The peak at 6 hours is greater than at 24 hours, suggesting that cytokine
presence is greatest at 6 hours instead of 24 hours. IL-1β is elevated at 6 hours and this elevation
is detectable up to 24 hrs. This is significant because this peak proliferation of IL-1β occurs
hours earlier than previously thought. Differences in IL-1β levels were statistically significant
between 0 and 24 hours (p= 0.07), 1 to 6 hours (p=0.01) and 1 to 24 hours (p= 0.07). However,
the level of IL-1β between 6 and 24 hours is not statistically significant.
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Figure 6: Levels of IL-1β in MB Sites during Retie Time Points
There was a statistical significant increase in IL-1β at the recall appointment between 6 hours
and 24 hours (p= 0.07). Both initial and retie appointments show peak proliferation of IL-1β at
6 hours. Values are shown as fg of IL-1β per μg of total protein.
At the retie appointment, IL-1β exhibited a similar expression pattern as the initial
appointment. From the graph above, levels of IL-1β were elevated at 6 hours and 24 hours
compared to 0 hours and 1 hour. The peak at 6 hours was greater than 24 hours. At both the
initial and retie time points, the expression of IL-1β peaked at 6 hours rather than 24 hours. The
difference of IL-1β levels is statistically significant between 6 and 24 hours (p= 0.07).
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Figure 7: Levels of IL-1β at DL sites during Initial Visit Time Points
Although total IL-1β protein was highest at 24 hours at the DL site during initial visit, the
differences when compared to the values at 0, 1, and 6 hours were not statistically significant.
Values are shown as fg of IL-1β per μg of total protein.
When measuring IL-1β levels at the DL experimental sites during the initial visit time
points, levels were elevated at 6 hours and 24 hours compared to 0 hours and 1 hour. The peak
elevation of IL-1β was identified at the 24 hour time point instead of the 6 hour time point, as
observed in MB sites. However, these differences in elevation at the DL sites are not statistically
significant.
Previous studies have shown IL-1β to peak 24 hours after orthodontic force activation
(Grieve et al., 1994). However, the study did not distinguish a tension and compression side, nor
did they compare findings from the MB side to the DL side. At the DL site, this present study
supports the findings that IL-1β peaks 24 hours after force activation.
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Figure 8: Levels of IL-1β at DL Site during Retie Appointments
At the retie appointment, IL-1β protein levels were highest at 24 hours compared to 0, 1, and 6
hours. The increase is statistically significant at 24 hours compared to 1 hour (p= 0.07) and
compared to 6 hours (p= 0.07). Values are shown as fg of IL-1β per μg of total protein.
At the retie appointment, levels of IL-1β at the DL experimental sites were higher at 0
hours and 24 hours compared to 1 hour and 6 hours. The peak elevation of IL-1β was identified
at 24 hours. The retie results slightly differed from the initial visit results as IL-1β was higher at
0 hours compared to 6 hours at the retie visit. However, both time points showed congruent data
that IL-1β levels peaked at 24 hours post force activation.

At the retie appointment, the

differences in IL-1β levels measured at the DL sites were statistically significant between 1 and 6
hours (p= 0.02), 1 and 24 hours (p= 0.07), and 6 to 24 hours (p= 0.07).

35

IL-17 Levels
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Figure 9: Levels of IL-17 at MB Sites during Initial Visit Time Points
IL-17 peaked at 24 hours after force activation and was statistically significant compared to
levels at 6 hours (p= 0.09). Values are shown as fg of IL-17 per μg of total protein.

Levels of IL-17 peaked at 24 hours at the MB site during the first visit time points.
Unlike IL-1β where the greatest levels were measured at 6 hours after force activation, levels of
IL-17 at that time point were the lowest.

IL-17 levels was greatest at 24 hours but was not

statistically significant when compared to 0, 1 hours. The difference in measurements was
statistically significant between 6 and 24 hours (p= 0.09).
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Figure 10: Levels of IL-17 at MB Site during Retie Appointments
At the retie appointment, levels of IL-17 at the MB site were highest at 24 hours. The peak was
statistically significant when compared to 0 hours (p= 0.09) and compared to 1 hours (p= 0.09).
Values are shown as fg of IL-17 per μg of total protein.
At the retie appointment, IL-17 levels were higher at 6 hours and 24 hours compared to 0
hour and 1 hour. The peak was measured at 24 hours. The peak following activation during the
retie visit is consistent with the peak following activation at the initial appointment. This
suggests that the peak expression of IL-17 occurs at 24 hours at the MB site during orthodontic
tooth movement. The differences in IL-17 levels were statistically significant between 0 and 24
hours (p= 0.09) and from 1 and 24 hours (p= 0.09).
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Figure 11: Levels of IL-17 at DL sites during Initial Visit Time Points
At the DL site, IL-17 peaked at 1 hour after force activation. The increase is statistically
significant compared to 24 hours (p= 0.01). Values are shown as fg of IL-17 per μg of total
protein.

Levels of IL-17 measured at the DL site during the initial visit time points did not exhibit
a gradual increasing pattern of expression. Levels measured at 0 hour, 1 hour and 24 hours are
higher than levels measured at the 6 hour time point. The peak was measured at the 1 hour time
point. From the results gathered during the initial visit time points, there seems to be no
temporal pattern of expression for IL-17 at the DL site. However, the differences in total IL-17
values were statistically significant between 0 and 6 hours (p= 0.004), 0 and 24 hours (p= 0.08),
between 1 and 6 hours (p=0.006) and between 6 and 24 hours (p= 0.007).
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Levels of IL-17 at Retie Visit Time Points
(DL sites)
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Figure 12: Levels of IL-17 at DL Site during Retie Appointments
IL-17 levels were highest at 1 hour after force activation. This corresponds to findings from the
initial visit and was statistically significant compared to 24 hours (p= 0.01). Values are shown as
fg of IL-17 per μg of total protein.

For the retie visit, there is also no gradual increasing pattern of IL-17 expression. Levels
measured at 0 hour, 1 hour, and 24 hour time points were higher than at 6 hours. This is
consistent with the findings from the initial visit that IL-17 levels were lowest at the 6 hour time
point. Highest levels were measured at 24 hours. The retie results and initial visit results show
no consistent temporal pattern of expression for IL-17. The differences in levels of IL-17 were
statistically significant between 0 to 6 hours (p= 0.09), 0 to 24 hours (p= 0.004), and 1 to 24
hours (p= 0.01).
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Chapter V
Discussion
Periodontal Condition
The periodontal conditions in our subjects were evaluated at initial and retie
appointments. Although there was some slight marginal inflammation in localized areas due to
position of brackets and hooks, no patients were excluded due to poor hygiene or severely
inflamed tissue. This was attributed to subjects’ good home care and oral hygiene. The interval
between the initial and retie appointment was 5-7 weeks. The short duration of this study was
selected to ensure optimal gingival health.

Studies show that although it is achievable to

maintain good oral hygiene throughout orthodontic treatment, duration in fixed appliances is an
important factor in the health of gingival tissues (Skidmore et al., 2005).
All patients did not exhibit plaque accumulation on teeth or moderate gingival
inflammation. Although our patients had good oral hygiene, it is possible that some levels of
subgingival inflammation could not be detected clinically, which could account for higher levels
of IL-1β and IL-17 in some samples.
Sample Age
The sample age in this study ranged widely from 11-31 years of age (mean 17.445).
Although Ren et al. (2002) reported that cytokine levels (PGE2, IL-6) in adolescents reflect
changes in inflammation more accurately than cytokine levels in adults, information from both
groups is important as demand for orthodontics from adult patients is increasing. Currently,
there is little information on inflammatory mediators in GCF during orthodontic tooth movement
in adults, thus future research can focus on comparing levels of IL-1β and IL-17 at different time
points in different age groups and determine if cytokine levels vary with age.
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Gingival Crevicular Fluid Volume
This study analyzed levels of IL-1β and IL-17 in gingival crevicular fluid after
application of orthodontic force during different time points. GCF samples were collected from
9 patients undergoing treatment at the UNLV Orthodontic Clinic at their initial bonding
appointment and at their first retie appointment. Baseline samples were collected prior to any
application of force. Experimental samples were collected at 1, 6, and 24 hours after orthodontic
force application for during the initial and retie appointments.
There was not a statistically significant difference in GCF volumes between the inital and
retie visits for the control and experimental samples. However, when comparing control sample
volumes to the experimental sample volumes, GCF volumes were higher in the experimental
group.
Many studies have shown that GCF volume is a reliable and suitable source for
biomarkers for tissue remodeling during orthodontic treatment (Kapoor et al., 2014). Many
studies have also used GCF as the source for analyzing biomarkers and cytokine levels. In a
systematic review completed by Kapoor et al. (2014), findings concluded that the altering levels
of biomarkers in GCF corresponding to force application are indicative of the underlying
biological remodeling processes in bone and periodontium during orthodontic tooth movement.
RANKL, OPG, IL-1β, IL-6, TNF-α in GCF peaked at 24 hours after force activation (Kapoor et
al. 2014) All of the studies analyzed in Kapoor’s systematic review evaluated GCF samples
collected 1 hour and 24 hours after force activation. Our study includes those time points in
addition to evaluating samples collected at 6 hours after force activation.
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There are also studies that show there is no statistically significant difference in GCF
volumes of orthodontically treated teeth compared to control teeth, suggesting GCF cannot be
used as an indicator of tooth movement. Drummond et al. (2011) conducted studies to evaluate
if orthodontic tooth movement leads to significant changes in GCF volumes. They found that
GCF volume is not a reliable method for evaluating tissue remodeling because changes in GCF
volume were not statistically significant during orthodontic treatment. The small changes they
saw between experimental and control teeth were attributed to subclinical tissue inflammation.
These conflicting conclusions can be attributed to differences in patient population and oral
hygiene, as well as study design and time points at which GCF samples were collected.
Since there was no statistically significant difference between the initial and retie
appointments for GCF volumes within the same sample groups, further analysis examined GCF
volumes by hours after force activation (0, 1, 6, and 24 hours). Experimental samples at 1, 6 and
24 hours showed higher GCF volume when compared to the control samples at every time point.
In addition, GCF samples collected at the 6 hour time point from the experimental teeth showed
a statistically significant increase in GCF volume compared to all other experimental time points.
This is important as all other studies analyzing GCF volume during tooth movement have never
measured volumes after 6 hours of orthodontic force application. The peak in GCF volume at
this time point may suggest that inflammation associated with orthodontic tooth movement may
also be at its peak. Since the 6 hour time point had the highest volume, further studies of GCF
volumes at this time point may provide valuable information about the optimal time for assaying
the level of inflammation induced by tissue remodeling.
Our study supports the conclusion that GCF volume does increase in teeth undergoing
orthodontic treatment compared to control.

The highest volume of GCF collected also
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corresponds to the highest levels of IL-1β detected, both of which occurred at the 6 hour time
point. This is significant because it shows that the elevation of IL-1β at 6 hours is not attributed
to a relative decrease in total GCF volume. The elevation measured at the 6 hour time point is
due to an increase in the expression of IL-1β.

This shows that GCF is a reliable source to

evaluate cytokine levels and is reflective of the microenvironment of periodontal tissues.
IL-1β Levels
IL-1β has been shown to induce osteoclastogenesis and play a critical role in bone
resorption and apposition during orthodontic tooth movement. Previous studies of IL-1β in
gingival crevicular fluid all analyzed its presence at 1 and 24 hours after force activation (Duduc
et al., 2006). There are no studies analyzing IL-1β in tension vs compression sites collected
from GCF at 6 hours post force activation. Therefore the general consensus has been that the
peak expression of IL-1β occurs 24 hours after force activation.
Although other studies have suggested that peak IL-1β levels occurs 24 hours after force
activation, this present study resulted in peak expression of IL-1β at 6 hours with a slight
decrease at 24 hours. The decrease is statistically significant from 6 hours to 24 hours. This
indicated that IL-1β peaks earlier than previously thought. Since no other study has evaluated
IL-1β in GCF volume at this time point, IL-1β peaking at 6 hours may suggest that the
inflammatory process is at its height during that time point. The inflammatory response is
almost immediate after force activation, which possibly allows tooth movement to occur earlier.
As tooth movement occurs earlier, clinicians could potentially shorten retie intervals and speed
up treatment time.
The small GCF sample volumes (ranging from 0.1 to 4.3 μl) were diluted in PBS to a
total volume of 200 μl so the concentration of our total protein in the working volume of PBS is
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incredibly low. Some samples yielded no results when analyzed because the minimal detectable
threshold of IL-1β was not present. Patient samples also exhibited highly variable readings of
total protein, IL-1β and IL-17. Due to the high variability, our standard deviation was large,
rendering many measured differences not significant. In many cases, there was a clear total
value difference at each time point, but due to the high standard of error, some differences were
not statistically significant. The wide range of results for some samples can be attributed to a
plethora of reasons including patient variability, genetic differences, undetected subgingival
inflammation, and varying force levels applied to teeth. Tooth movement depends on physical
characteristics such as amount of force applied, as well as biological characteristics such as PDL
size and genetic variability (Rygh and Brudvik, 1995). Thus each patient will most likely have
varying rates of tissue response as evidenced by our samples.
IL 17
IL-17 has recently been identified as a cytokine involved in root resorption during
orthodontic tooth movement (Aihara et al., 2013). Relatively little research has been done
examining its role in bone turnover during orthodontic tooth movement. In a comprehensive
review by Kumar et al. (2015), IL-17 was not listed as a known biomarker for orthodontic tooth
movement. However, recent studies have shown elevated levels of IL-17 in patients with severe
root resorption and concluded that IL-17 plays a role in root resorption by enhancing the
expression of RANKL in PDL to initiate osteoclastogenesis (Nakano et al., 2015). Thus, a link
has been made correlating IL-17 with bone remodeling during orthodontic tooth movement. To
further investigate the role of IL-17, this present study examined the presence of IL-17 in GCF at
several different time points.
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In this present study, IL-17 peaked at 24 hours during both the initial and retie visits at
the MB site. At the 6 hour time point, our initial and retie data are not analogous. At the initial
appointment, levels at 6 hours were the lowest, while at the retie visit, levels at 6 hours were
greater compared to 0 hour and 1 hour. Further research needs to be completed in order to
establish a definitive timeline for the expression of IL-17.
Since IL-17 plays a role in both bone resorption and bone deposition, it was hypothesized
that levels would be detected at both sites. At the MB site, IL-17 levels peaked at 24 hours
during both the initial and retie appointments. However, our initial visit and retie data at the DL
site are incongruous. During the initial visit, IL-17 levels peaked at 1 hour compared to 24 hours
measured during the retie appointment. Our data for IL-17 at the DL site is inconclusive. This
could be attributed to the assumption that IL-17 expression would theoretically be greatest
during the post lag phase of tooth movement after removal of all necrotic bone by osteoblasts.
IL-17 can divert the differentiation of mesenchymal stem cells into an osteoblastic pathway
(Huang et al., 2006), which would mostly likely occur in the post lag phase characterized by
increased osteoblastic activity. Since the study did not extend to 40 days post force activation,
no conclusive data was gathered on the expression of IL-17 in DL sites. Further research needs
to be conducted to evaluate IL-17’s potential role in osteogenesis in orthodontic tooth movement.
From the raw data, levels of IL-17 were very similar across all patients and all time
points. Though some differences between sites and time points were statistically significant,
both sets of data showed similar total concentration levels. IL-17 has been detected at higher
levels in patients with severe root resorption due to excessive orthodontic force and in vitro
animal studies (Nakano et al., 2015). It could be possible that IL-17 is expressed in small
quantities during healthy orthodontic tooth movement and levels only spike when excessive

45

force is applied. Since this study used slow gentle force application, high levels of IL-17 would
not be expected to be detected. This can account for the generalized low levels of IL-17 present
in GCF across all time points in our results.

Low levels of IL-17 are needed for bone

remodeling, but high levels might be associated with pathological bone remodeling that leads to
root resorption. Higher levels of IL-17 are also detected in patients with periodontal disease.
Thus low levels of IL-17 during orthodontic tooth movement could also be an indicator of
periodontal health as well as root integrity.
Relationship between IL-1 β and IL-17
To determine if there is a relationship between the expression levels of IL-17 and IL-1β,
this current study analyzed levels of the two cytokines in GCF during orthodontic movement at
various time points. From our results, there is no temporal correlation between the expression of
IL-17 and IL-1β. Hwang et al (2004) have shown IL-17 to induce the production of IL-6 and IL8 in dental pulp cells. Although IL-6, IL-1β and IL-8 are pro-inflammatory cytokines that
regulate bone remodeling, there appears to be no direct influence on the expression of IL-1β via
IL-17. Currently, no literature has compared the expression levels of IL-17 to IL- 1β during
orthodontic tooth movement. From our results, we conclude that IL-17 does not have a similar
temporal expression pattern as IL- 1β and seems to have no temporal relationship with IL- 1β,
but IL-17 can be used as a predictive factor for abnormal or aggressive inflammation.
MB and DL Sites
The present study investigated GCF from two opposite sites (mesiobuccal and
distolingual) on the same experimental tooth. Samples from opposite sites were collected to
analyze the cytokines present at the compression and tension sides of tooth movement. All of our
experimental teeth were incisors, thus rotation and not translation was the projected movement
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during the time frame of this study. From study models, it was predicted that bone resorption
would more likely to occur on the MB side of the experimental teeth and was designated the
compression site. The DL side was designated the tension site. However, because the movement
of the tooth is mostly rotational and not translation, it was not possible to accurately designate
either site as the purely a compression or tension side. Despite this limitation, small differences
were noted between the MB and DL sites. In measuring levels of IL-1β and IL-17, a statistically
significant difference between the MB and DL experimental sites were identified for most time
points. While it is difficult to accurately assign a pure tension and compression site, it is clear
that orthodontic forces affect protein levels in resorption and apposition sites in varying
magnitudes.
In the present study, IL-1β increased at 6 hours and 24 hours compared to baseline values
and compared to control sites. Our observed changes in GCF composition support the theory
that exogenous forces cause an inflammatory reaction at both the tension and compression sites.
The differences in protein composition between the MB and DL sample sites may reflect the site
specific recruitment of cytokines that occurs during orthodontic tooth movement. However,
there are no studies that analyze the site-specific sequential recruitment of cytokines, specifically
between the MB and DL sites on the same tooth. GCF studies of cytokines during orthodontic
movement only differentiate between an experimental site and a control site (Grieve et al.,
1994). This limitation is exacerbated by the continuous nature of the PDL where GCF is freeflowing between all surfaces. This makes it difficult to attribute tissue remodeling biomarkers to
one specific site in the PDL.
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Initial vs Retie Visits
Nickel titanium wires are capable of withstanding large deflections and slowly return to
their original shape on deactivation which translates gentle moderate forces to align teeth
(Burstone et al., 1985). Due to its high spring-back property and low load deflection rate, there
might be some residual activation still present at 0 hours at the retie visit. This residual activation
of the nickel titanium orthodontic wires could explain the elevated level of IL-1β at 0 hours at
the retie visit compared to initial visit.
Future Research
Future studies can be performed with more time points and more patients. The sample
size in this study was 9. A larger sample size could provide more conclusive and generalized
data for all populations. Studies can focus on specific patient populations to gather data on
specific groups such as male, female, age, ethnicity etc. More patients can also increase data
points to garner more statistically significant results. In this study, we examined IL-1β and IL-17
expression at 0, 1, 6 and 24 hours after activation. It would be interesting to look at more time
points between 1 hour and 24 hours activation since this present study is the first study to do so.
GCF could be collected at 12 and 16 hours activation to complete a detailed expression timeline
of IL-1β and IL-17.
If this study were to be conducted again, alternative methods could be used to increase
detection sensitivity of IL-1β and IL-17 in our samples. Since our sample concentrations are
very low and diluted further in the protocol, detection beads with greater sensitivity can help
detect femtomolar cytokine levels and add to our data pool.
Other candidates associated with orthodontic tooth movement and tissue remodeling,
such as TNF-alpha, IL-8, IL-16, can also be evaluated to analyze its temporal expression pattern.
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Chapter VI
Conclusions
1.

Gingival crevicular fluid volume increases after orthodontic forces are applied. This
most likely is a reflection of the increased proteins and cytokine present in the
periodontium due to inflammation from mechanical stimulus. In the present study, GCF
fluid volume at the experimental sites peaked at 6 hours post force application and
remained elevated at 24 hours post force application, suggesting that the inflammatory
pathway is heightened during those time points.

2. IL-1β levels in GCF increased during orthodontic tooth movement at both the MB and

DL sites and were highest at 6 hours post force application at the MB site. While all
previous studies reported levels of IL-1β peaking at 24 hours, these studies did not
measure levels between 1 and 24 hours. Levels of IL-1β peaking at 6 hours may imply
that the inflammatory response is most reactive at 6 hours post force application.
3. IL-17 is detectable in the GCF during initial tooth movement. In contrast to the peak

observed with IL-1β at 6hrs, IL-17 peaked at 24 hours at the MB site. It is possible that
better detection methods or additional patients and sites may help to determine smaller
variations in IL-17 at compression and tension sites. This may also help with defining a
temporal relationship between IL-1β and IL-17.
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